Viewing Study NCT04009460


Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2025-12-31 @ 2:22 PM
Study NCT ID: NCT04009460
Status: TERMINATED
Last Update Posted: 2022-04-29
First Post: 2019-07-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Solid Tumors
Sponsor: Elpiscience Biopharma, Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module